Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$1,020 Mln
P/E Ratio
358.67
P/B Ratio
13.93
Industry P/E
--
Debt to Equity
0.28
ROE
0.04 %
ROCE
3.47 %
Div. Yield
0 %
Book Value
0.57
EPS
0.02
CFO
$52.29 Mln
EBITDA
$-234.71 Mln
Net Profit
$-272.76 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
| 4.47 | -2.98 | -1.82 | 16.07 | -1.94 | -- | -- |
|
BSE Sensex*
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
Enfusion Inc (ENFN)
| 6.13 | 0.31 | -53.82 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 7.31 | 12,828.13 | -- | -38.76 | |
| 69.52 | -- | 563.55 | 0.18 | |
| 192.33 | 10,680.60 | 49 | 20.06 | |
| 22.31 | 9,191.21 | -- | -20.84 |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time... investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois. Address: 125 South Clark Street, Chicago, IL, United States, 60603 Read more
CEO & Director
Mr. Oleg Movchan
Chief Financial Officer
Mr. Bradley Herring
Headquarters
Chicago, IL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Enfusion Inc (ENFN) stood at $ 143 Mln as on 31-Dec-24
The share price of Enfusion Inc (ENFN) is $10.76 (NYSE) as of 17-Apr-2025 16:04 EDT. Enfusion Inc (ENFN) has given a return of -1.94% in the last 3 years.
Enfusion Inc (ENFN) has a market capitalisation of $ 1,020 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Enfusion Inc (ENFN) is 358.67 times as on 17-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Enfusion Inc (ENFN) and enter the required number of quantities and click on buy to purchase the shares of Enfusion Inc (ENFN).
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois. Address: 125 South Clark Street, Chicago, IL, United States, 60603
The CEO & director of Mr. Oleg Movchan. is Enfusion Inc (ENFN), and CFO & Sr. VP is Mr. Bradley Herring.
There is no promoter pledging in Enfusion Inc (ENFN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,087
|
|
|
1,028
|
|
|
879
|
|
|
871
|
| Enfusion Inc (ENFN) | Ratios |
|---|---|
|
Return on equity(%)
|
4.45
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
1.4
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Enfusion Inc (ENFN) was $0 Mln.
$-0.04
(
